Saratov JOURNAL of Medical and Scientific Research

The problem of comorbidity in migraine without aura

Year: 2022, volume 18 Issue: №1 Pages: 138-142
Heading: Тhematic supplement Article type: Original article
Authors: Salina Е.А., Parsamyan R.R., Mudrak D.A., Tsilina Yu.I., Shitova Yu.A., Kolokolov O.V.
Organization: Saratov State Medical University

Objective: to analyze the frequency of occurrence and structure of comorbid disorders in patients with rare episodic, frequent episodic and chronic migraine without aura. Material and methods. Outpatient records of 159 patients with migraine without aura were analyzed: 52 with rare episodic migraine (REM), 54 with frequent episodic migraine (FEM), 53 with chronic migraine (CM). All patients underwent a clinical and psychological examination with an assessment of the state of the temporomandibular joint, frontal, occipital muscles, neck muscles (pericranial muscles) and chewing muscles with an emphasis on the pterygoid muscles. All patients were consulted by a clinical psychologist. Results. Additional headache symptoms have been identified in various forms of migraine. In the structure of comorbid conditions, the following were noted more often than others: disorder of pericranial muscles (REM 59.6%, FEM 72.2%, CM 90.5%), dysfunction of the temporomandibular joint (REM 21.1%, FEM 22.2%, CM 54.7%), anxiety-depressive disorders (REM 26.9%, FEM 35.2%, CM 58.5%), insomnia (FEM 22.2%, CM 39.6%). With CM, there is a high percentage of medication-overuse headache (73.6%). Conclusion. Comorbid disorders occur with varying frequency depending on the form of migraine. Among comorbid disorders, muscle dysfunction, dysfunction of the temporomandibular joint, anxiety and depressive disorders, and sleep disorders predominate.

1. Osipova VV. Migraine: clinic, diagnosis and treatment approaches. Pharmateka 2008; (20): 43-7.
2. Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 2020; 21 (1): 23.
3. Tachibana H. Comorbidity in migraine. Rinsho Shinkeigaku 2022; 62 (2): 105-11.
4. The International Classification of Headache Disorders, 3rd ed. Cephalalgia 2018; 38 (1): 1-211.
5. International Classification of Orofacial Pain, 1st ed. (ICOP). Adapted Russian version. Almanac of Clinical Medicine 2022; 50 (Suppl): 1-82.
6. Bendtsen L, Jensen R, Jensen NK, Olesen J. Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia 1995; 15 (3): 205-10.
7. Osipova VV. Pericranial muscle dysfunction in primary headache and its correction. Neurology, neuropsychiatry psychosomatics 2010; (4): 29-36.
8. Zenkevich AS, Filatova EG, Latysheva NV, et al. Migraine and temporomandibular joint dysfunction: mechanisms of comorbidity. S.S. Korsakov Journal of Neurology and Psychiatry 2015; 115 (10): 33-8.
9. Zenkevich AS, Filatova EG, Latysheva NV. Migraine and comorbid pain. Medical Council 2016; (8): 106-15.
10. Mia ТМ, Beasse De Dhaem О, Kroon Van Diest A, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016; 87 (7): 741-9.
11. Tiseo C, Vacca A, Felbush A, et al. Migraine and sleep disorders: A systematic review. Pain 2020; 21 (1): 126.
12. Bayushkina LI, Naprienko MV Problem of chronic migraine comorbidity. J Medical Review 2018; (9): 37-40.

2022_01-1_138-142.pdf348.97 KB

No votes yet